NEW YORK, January 19, 2017 /PRNewswire/ --

Ally Financial Inc. (ALLY)

Lifshitz & Miller announces investigation on behalf of ALLY investors concerning whether ALLY adequately disclosed information regarding loan delinquency rates.

If you are an ALLY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Amphastar Pharmaceuticals, Inc. (AMPH)

Lifshitz & Miller announces investigation on behalf of AMPH investors concerning whether AMPH adequately disclosed Primatene Mist prospects.

If you are an AMPH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Lannett Company, Inc. (LCI)

Lifshitz & Miller announces investigation on behalf of LCI investors concerning whether LCI adequately disclosed LCI's drug pricing methodologies sustainability.

If you are an LCI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. 

Live Ventures Incorporated (LIVE)

Lifshitz & Miller announces investigation on behalf of LIVE investors concerning whether LIVE engaged in a stock pumping scheme.

If you are a LIVE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

MiMedx Group, Inc. (MDXG)

Lifshitz & Miller announces investigation on behalf of MDXG investors concerning whether MDXG improperly recognized revenue.

If you are a MDXG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (
516)493-9780 or e-mail at [email protected].

Seattle Genetics, Inc. (SGEN)

Lifshitz & Miller announces investigation on behalf of SGEN investors concerning whether SGEN adequately disclosed the risks of vadastuximab talirine.

If you are an SGEN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Teligent, Inc. (TLGT)

Lifshitz & Miller announces investigation on behalf of TLGT investors concerning whether TLGT's management engaged in a price fixing scheme.

If you are a TLGT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

TerraVia Holdings, Inc. (TVIA)

Lifshitz & Miller announces investigation on behalf of TVIA investors concerning TVIA's disclosures regarding its products causing gastrointestinal distress.

If you are a TVIA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Zimmer Biomet Holdings, Inc. (ZBH)

Lifshitz & Miller announces investigation on behalf of ZBH investors concerning whether ZBH adequately disclosed its supply chain problems.

If you are a ZBH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-ally-financial-inc-amphastar-pharmaceuticals-inc-lannett-company-inc-live-ventures-incorporated-mimedx-group-inc-seattle-genetics-inc-teligent-inc-terravia-ho-300393792.html

SOURCE Lifshitz & Miller Law Firm